GRCL logo

Gracell Biotechnologies Inc. American Depositary Shares


GRCL: Gracell Biotechnologies Inc is a clinical-stage biopharmaceutical company focused on developing and discovering cell and gene therapies to address and fulfill unmet medical needs in the treatment of cancer. The company aims to disrupt conventional approaches to CAR-T cell therapies with its proprietary technology platforms-FasTCAR and TruUCAR.


Show GRCL Financials

Consumer Interest
SEC Filings

Recent trades of GRCL by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by GRCL's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of GRCL in WallStreetBets Daily Discussion


Recent insights relating to GRCL

CNBC Recommendations

Recent picks made for GRCL stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in GRCL

Corporate Flights

Flights by private jets registered to GRCL